UPDATED ALCOHOL WITHDRAWAL RECOMMENDATIONS Summary of Key Changes New Pabrinex® prescription recommendations for patients ‘at risk’ of Wernicke’s Encephalopa...

Formulary Update (August 2017)

Posted: September 04, 2017.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Hepatitis B Vaccine Supply Update

Posted: August 30, 2017.
Category - Medicines Update

Highlights the current shortage of adult hepatitis B vaccine.

MHRA Updates July & August 2017

Posted: August 28, 2017.
Category - Medicines Update

Drug Safety Update (August 2017) includes: Ibrutinib (Imbruvica ...

Oral NSAIDs – What’s new?

Posted: August 25, 2017.
Category - Medicines Update

The GGC Oral NSAID guideline has recently been updated. Ibuprofen and naproxen remain the NSAIDs of choice. The prescribing notes have been updated and include additional information on acute kidney injury and hepatic impairment.

MUE 06: Oral NSAIDs - An Update

Posted: August 25, 2017.
Category - Medicines Update Extra

Oral NSAIDs - An Update

** This bulletin supersedes PostScript Extra No. 24 **

There is considerable variation in individual response and tolerance to NSAIDs, but little difference in anti-inflammatory activity.
All NSAIDs should be avoided if possible in patients with a history of vascular disease, a high risk of cardiovascular disease (CVD), or gastrointestinal (GI) risk factors.
Treatment choice depends on individual response, risk factors and adverse effects, particularly GI and cardiovascular (CV) complications.
The lowest effective dose to control the patient’s symptoms, for the shortest duration possible, should be used. The use of ‘as required’ NSAIDs should be considered where appropriate.
The preferred non-selective NSAIDs are ibuprofen or naproxen. A proton pump inhibitor (PPI) may be required depending on GI risk.

Zomorph® - Preferred Brand Oral Morphine M/R in Adults

Posted: August 25, 2017.
Category - Medicines Update

MST® is currently the most frequently prescribed brand of morphine sulphate modified release (M/R) across NHSGGC. From 01/09/2017 the preferred choice of solid morphine sulphate M/R across primary and secondary care will change to Zomorph® capsules.

Showing 71 - 80 of 675 records. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

← Previous page | Next page →